National Health (Pharmaceutical Benefits Early Supply) Amendment Instrument 2015 (No. 9) specification under subsection 84AAA(2) (PB 103 of 2015) (Cth)

PB 103 of 2015

National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 9) – specification under subsection 84AAA(2)

National Health Act 1953

I, PAUL CREECH, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated    23 October 2015

PAUL CREECH
First Assistant Secretary (Acting)
Pharmaceutical Benefits Division
Department of Health

___________________________________________________________________________

Amendment determination – Pharmaceutical Benefits – Early Supply

1          Name of Instrument

(1)   This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 9) – specification under subsection 84AAA(2).

(2)This Instrument may also be cited as PB 103 of 2015.

2          Commencement

This Instrument commences on 1 November 2015.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).

Schedule 1        Amendments

1. Schedule 1, after entry for Pindolol in the form Tablet 15 mg

   insert:

Ponatinib	Tablet 15 mg (as hydrochloride)	Oral	60	5	60
	Tablet 45 mg (as hydrochloride)	Oral	30	5	30